Results 31 to 40 of about 1,168 (170)
BMC Endocrine Disorders, 2023 Background Giant prolactinoma (> 4 cm in dimension) is a rare disorder. Invasive macroprolactinoma has the potential to cause base of skull erosion and extend into the nasal cavity or even the sphenoid sinus.
Danting Li +4 more
doaj +1 more source
Giant prolactinomas in women [PDF]
European Journal of Endocrinology, 2014 ObjectiveTo characterise distinctive clinical features of giant prolactinomas in women.DesignA multicentre, retrospective case series and literature review.MethodsWe collected data from 15 female patients with a pituitary tumour larger than 4 cm and prolactin levels above 1000 μg/l and identified 19 similar cases from the literature; a gender-based ...
Delgrange, Etienne +8 more
openaire +4 more sources
Turkish Journal of Internal Medicine, 2022 Objective: Data on whether there is a histopathological difference in cellular features as determined with Ki-67 between giant prolactinomas and smaller macroprolactinomas are not fully clear.
Soner Cander, Özen Öz Gül
doaj +1 more source
supplementary data for study 'Giant prolactinoma in childhood and adolescents: a single-center experience and systematic review'. [PDF]
, 2022 This is supplementary information to study 'Giant prolactinoma in childhood and adolescents: a single-center experience and systematic review'
Saba Memon (10040513) +1 more
core +1 more source
International Journal of Osteoarchaeology, Volume 33, Issue 6, Page 1095-1100, November/December 2023., 2023 Abstract Hyperostosis frontalis interna (HFI) is an osseous overgrowth characterized by symmetrical, irregular bone apposition on the internal table of the frontal bone, which preferentially occurs in females. In 1719, Morgagni described the condition as one sign of a triad comprising HFI, hirsutism, and obesity (Morgagni's syndrome).
Stefan Flohr +2 more
wiley +1 more source
Immunity, Inflammation and Disease, Volume 11, Issue 10, October 2023., 2023 Abstract Background Pituitary adenoma (PA) is a type of tumor that develops in the sella turcica and is one of the most frequent intracranial tumors. It belongs to a type of adenoma derived from a single clone of cells in the pituitary gland. PA ranks third among all intracranial tumors, following only gliomas and meningioma.
Ling Wang, Dingkai Xu
wiley +1 more source
Andrology, Volume 11, Issue 7, Page 1398-1407, October 2023., 2023 Abstract Background Men harboring prolactinomas frequently suffer from central hypogonadism with secondary anemia. They present insidious and nonspecific symptoms of hypogonadism, making it difficult to diagnose the disease and determine its duration. The result is a delay in diagnosis, which may have harmful hormonal and metabolic consequences.
Yaron Rudman +6 more
wiley +1 more source
Clinical Case Reports, Volume 11, Issue 9, September 2023., 2023 Key Clinical Message Kidney metastasis to the pituitary gland can cause hyperprolactinemia even above 250 ng/mL. Although the treatment of metastasis is palliative, surgical decompression could play a major role in the recovery of symptoms and improve quality of life.
Ali Mazar‐Atabaki +4 more
wiley +1 more source
Giant prolactinomas: the therapeutic approach [PDF]
Clinical Endocrinology, 2013 AbstractBackgroundGiant prolactinomas are an unusual subset of macroprolactinomas and are more commonly found in men. The goal of this review is to propose a giant prolactinoma definition and discuss the available therapeutic options for biochemical and tumour volume control.MethodsA comprehensive search of all published studies was performed ...
Aline B, Moraes +3 more
openaire +2 more sources
Brain and Behavior, Volume 13, Issue 7, July 2023., 2023 We investigated the potential perioperative risk factors for postoperative delirium in pituitary adenoma patients treated by endoscope‐assisted transsphenoidal surgery. We found that lower IGF‐1 and CRH levels were tightly associated with postdelirium and high levels of blood glucose (GLU) after surgery.
Jin Liu +9 more
wiley +1 more source